Smaller, greener and more accurate. Scratch that. Most accurate.1, 2, 3 The world’s leading continuous glucose monitor (CGM) has extended its lead with this next-generation technology — the FreeStyle Libre 3 system— now cleared by the U.S. Food and Drug Administration for people ages 4 and up in the U.S. living with diabetes. The size of just two stacked U.S. pennies, Abbott’s FreeStyle Libre 3 system features the world’s smallest, thinnest1 and most accurate3 14-day glucose sensor on the market. The system automatically sends real-time, minute-by-minute glucose readings to a compatible smartphone4 without scanning, has the strongest Bluetooth range of any CGM,5,6,7 and uses significantly less plastic than previous versions.5 This technology also: Offers optional glucose alarms.4,6 Provides glucose history and trend arrows with a quick look at your phone.4 Integrates with LibreLinkUp8 (smartphone app) and LibreView (cloud-based data system), enabling caregivers and healthcare professionals to remotely monitor loved ones and patients as needed.9, 10 And all of this for the same price as the FreeStyle Libre 2 system. Translation: Managing diabetes just got even more discreet,11 seamless,6 reliable6 and better for the environment.11 “The FreeStyle Libre 3 system is a game changer for the millions of people living with diabetes. It’s a direct result of listening to our customers and giving them the innovation and sensing technology they’ve been looking for,” said Jared Watkin, senior vice president, Diabetes Care, Abbott.